7.2
Neonatal/Newborn Disorders
- This section covers basic medical management of neonatal disorders and long‐term sequelae which may affect the patient and their anesthetic management into childhood and beyond
Premature Birth
- Live infant delivered before 37 weeks
- Gestational age (GA) and birth weight (BW) are used to predict morbidity/mortality (Figure 7.3)
- Etiology/Risk Factors
- 70–80% result from preterm labor or premature rupture of membranes
- 20–30% are initiated by health care providers because of health concerns for mother or child
- Maternal risk factors:
- Prior preterm birth
- <17 or >35 years of age
- Lower socioeconomic status
- Short interpregnancy interval
- Overweight
- Underweight or low gestational weight gain
- Conception by assisted reproductive technology
- Pregnancy with multiples
- Substance use, including smoking
- Prevalence
- 5–18% of births worldwide
- Varies by race and ethnicity in US. Below stats according to Center of Disease Control:
- Non‐Hispanic Blacks 14.1%
- Hispanic 9.7%
- Non‐Hispanic White 9.1%
- Associated with 30% of all infant deaths in US
- Treatment
- Benign to symptomatic
- Depends highly on BW and GA
- Primary Concerns
- ↑ Risk of bronchopulmonary dysplasia (BPD) and subsequent reactive airway disease
- ↑ Risk of pulmonary hypertension
- ↑ Risk of developmental disabilities
- ↑ Risk of CHD
- ↑ Risk intraventricular hemorrhage
- Evaluation
- History
- GA at birth
- Time in NICU
- Need for supplemental oxygen, intubation, mechanical ventilation
- Home use of apnea monitors
- Persistent respiratory symptoms
- Consider cardiologist consult if congenital heart defect is present
- History
- Anesthesia Management
- ↑ Suspicion for airway reactivity
- For bronchospasm management see page 260
- Consider tracheomalacia if prolonged intubation in NICU
- ↑ Suspicion for airway reactivity
Respiratory Distress Syndrome (RDS)
- Etiology/Risk Factors
- Premature Birth
- C‐section
- Maternal diabetes
- Infection
- Rare in infants born after 30 weeks
- Pathophysiology
- Deficiency of pulmonary surfactant, which decreases alveoli surface tension, in immature lungs (Figure 7.4)
- Presents within minutes to hours of birth
- Rapid and shallow breathing
- Nasal flaring
- Grunting
- Tachypnea
- Progressive cyanosis and dyspnea
- Ultimately acidosis, hypotension, temperature instability, and apnea
- Treatment
- Goal of maintaining SpO2 > 90%
- Warm, humidified oxygen
- Nasal CPAP
- Exogenous surfactant via ETT
- Mechanical ventilation
- If uncomplicated, will resolve in three to four days
- Chronic disease can develop if oxygen requirement persists
- Primary Concerns
- Occurs in 75% infants born before 28 weeks GA
- May produce respiratory symptoms throughout childhood
- Evaluation
- History
- NICU course
- Requirement for supplemental oxygen and mechanical ventilation
- Persistent respiratory symptoms
- History
- Anesthesia Management
- ↑ Suspicion for airway reactivity
- For bronchospasm management see page 260
- Consider tracheomalacia if prolonged intubation
- ↑ Suspicion for airway reactivity
17–28 weeks GA | Alveoli begin to form |
28–36 weeks GA | Pulmonary capillaries form: Beginning of alveolar‐capillary barrier |
32–34 weeks GA | Surfactant production by type II pneumocytes |
Bronchopulmonary Dysplasia (BPD)
- Etiology/Risk Factors
- The main chronic complication of RDS
- Preterm birth
- Incidence ~40% in infants born before 28 weeks
- Prolonged ventilation and oxygen therapy
- Male gender
- Some evidence for maternal smoking
- Pathophysiology
- Exposure to mechanical ventilation and requirement of supplemental oxygen beyond 28 days of life
- Disrupts pulmonary development and causes lung injury
- Elevated oxygen requirement
- ↓ Lung compliance
- Reversible airway obstruction
- Exposure to mechanical ventilation and requirement of supplemental oxygen beyond 28 days of life
- Treatment
- Adequate nutrition
- Respiratory support as required
- Diuretics
- Inhaled and systemic corticosteroids
- Bronchodilators
- Most patients improve gradually as growth continues and healing occurs
- Primary Concerns
- Pulmonary symptoms persist for months to years
- Children who survive BPD have double the incidence of motor and cognitive delays [5]
- Evaluation
- Records
- Patient may have been followed by BPD clinic
- History
- Persistent respiratory symptoms
- NICU course
- Requirement for supplemental oxygen and mechanical ventilation
- Persistent respiratory symptoms
- Anesthesia Management
- ↑ Suspicion for airway reactivity
- For bronchospasm management see page 260
- Consider tracheomalacia in younger children who required mechanical ventilation
- Records
Apnea of Prematurity (AOP)
- Cessation of breathing for more than 20 seconds or shorter pauses associated with desaturation and/or bradycardia
- Etiology/Risk Factors
- Underdeveloped diaphragm
- Premature birth
- Hypoglycemia
- Hypoxia
- Anemia
- Hypothermia
- Sepsis
- Pathophysiology
- Blunted chemoreceptor response to hypercarbia and/or hypoxia (Figure 7.5)
- Treatment
- Treat and rule out possible underlying issues
- Anemia
- Infection
- Hypoglycemia
- Drugs
- IVH
- NEC
- Upper airway anomalies
- Seizures
- Feeding difficulty
- Head and neck positioning
- Prone positioning
- Supplemental oxygen
- CPAP
- IV or oral caffeine or theophylline administration
- Can be discharged to home without monitoring after 7–10 days free of apneic episodes
- Not a risk factor for SIDS
- Treat and rule out possible underlying issues
- Primary Concerns
- Almost all infants born before 28 weeks GA are affected
- Usually resolves by 36–37 weeks GA
- Evaluation
- History
- Perinatal course
- Requirement for supplemental oxygen and mechanical ventilation
- Home apnea monitor use
- History
- Anesthesia Management
- Incidence of postoperative apnea drops significantly after 35 weeks GA
- Consider tracheomalacia in younger children who required mechanical ventilation
- No known data/literature to guide perioperative management once AOP resolves.
Retinopathy of Prematurity (ROP)
- Visual impairment beginning in the neonatal period
- Etiology/Risk Factors
- Injury or premature birth disrupts normal angiogenesis
- Premature birth
- Hypotension
- Hypoxia
- Hyperoxia
- Pathophysiology
- 15–18 weeks GA
- Retinal vascularization begins
- 36–40 weeks GA
- Vascular development complete
- AAP guidelines suggest screening for all infants BW < 1500 g or GA < 30 weeks
- 15–18 weeks GA
- Treatment
- Based on disease severity
- Primary Concerns
- ↑ Risk of retinal detachment
- Evaluation
- History
- Consider ophthalmology consult
- Anesthesia Management